This randomised controlled clinical trial will investigate if a polypill (single pill containing fixed-dose combination of treatments) will improve patients adherence and health outcomes compared to patients given standard cardiovascular medications. The research will involve 1,000 patients at risk of a cardiovascular event determined by a formal assessment process. It will be conducted in Aboriginal Community Controlled Health Services and general medical practices in Australia. Participants in the study will be monitored for approximately 18 months.
The George Institute for Global Health
Head office
Level 13
321 Kent Street
Sydney NSW 2000
Ph: (02) 9657 0300
Fax: (02) 9657 0301
Email: info@georgeinstitute.org.au